Correction to: Discovery of novel pyruvate dehydrogenase kinase 4 inhibitors for potential oral treatment of metabolic diseases (Journal of Medicinal Chemistry (2019) 62:2 (575-588) DOI: 10.1021/acs.jmedchem.8b01168)

Dahye Lee, Haushabhau S. Pagire, Suvarna H. Pagire, Eun Jung Bae, Mahesh Dighe, Minhee Kim, Kyu Myung Lee, Yoon Kyung Jang, Ashok Kumar Jaladi, Kwan Young Jung, Eun Kyung Yoo, Hee Eon Gim, Seungmi Lee, Won Il Choi, Young In Chi, Jin Sook Song, Myung Ae Bae, Yong Hyun Jeon, Ga Hyun Lee, Kwang Hyeon LiuTaeho Lee, Sungmi Park, Jae Han Jeon, In Kyu Lee, Jin Hee Ahn

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

Page 586. ACKNOWLEDGMENTS section should include one more funding (text highlighted in italics): This work was supported by grants from Korea Drug Development Fund (KDDF-201601-03), the Korea Health, Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare (HI16C1501, HI12C1006), the Ministry of Science, ICT & Future Planning (MSIP)/National Research Foundation of Korea (NRF) (2016M3A9B6902868 and 2017R1A2B3006406), and GIST Research Institute (GRI) grant funded by GIST.

Original languageEnglish
Pages (from-to)2849
Number of pages1
JournalJournal of Medicinal Chemistry
Volume62
Issue number5
DOIs
StatePublished - 14 Mar 2019

Fingerprint

Dive into the research topics of 'Correction to: Discovery of novel pyruvate dehydrogenase kinase 4 inhibitors for potential oral treatment of metabolic diseases (Journal of Medicinal Chemistry (2019) 62:2 (575-588) DOI: 10.1021/acs.jmedchem.8b01168)'. Together they form a unique fingerprint.

Cite this